?Self-development is encouraged to be a specialist with research-oriented mind in a clinical conferencepreparingaresearch papera hematopathologicalconferenceCancer genome expert panel in our hospitalFigure in our article (Araki T, Kanda S, et al. JpnJ Clin Oncol 2023.)Oral presentation of research results at an international conference (Annualmeeting of American Society of Clinical Oncology 2023)preparation for seqat ASH34Hematology and Medical OncologyHematologyHematology and Medical OncologyMedical OncologyChief：Prof.Hideki MakishimaOutlook for students after graduation?It is encouraged to hold proactive motivation to lead as a researcher or a clinician Chief：Assoc. Prof. ShintaroKandaResearch subject?Clinical trials of cancer treatment in collaboration with multicenter clinical research groups such as the Japanese Clinical Oncology Group (JCOG) and related facilities in Nagano PrefectureOutlook for researchIt is a great pleasure to discover new findings in the field of cancer, an intractable disease. Clinical research in the field of cancer is often conducted at multiple institutions, and you will make friendships with researchers at other institutions in the course of such collaborative research.Outlook for students after graduation?Qualificationasamedicaloncologist??Feel the Dynamism of HematologyFoster professionals in the field of medical oncology and the clinical researchOurmissionsinhematologycoverawidespectrumofdiseasesandconditionsfromacommonillnesstoararediseaseentity.DuringfrequentencounterswithpatientschallengingintractableendofthespectrumofhematologicaldiseasesatShinshuUniversityHospital,welearnbothintensive/aggressivetreatmentstyleforacureofthediseaseandrespectful/modesttreatmentstyleforenhancingthehumandignity.Wetakebestadvantageofourteamworkforbettertreatmentatthehospitalandfordeeperunderstandingofthediseaseatourlaboratory.Research subject?Molecular analysis of pathophysiology of myelodysplastic syndrome?Development of cellular immunotherapy for intractable hematological malignancies?Pathophysiological analysis of NK/T cell malignancy and development for its treatment?Pathophysiological analysis of and clinical research for large granular lymphocytic leukemia and pure red cell aplasia Outlook for researchUnderstandingtheetiologyandpathophysiologyofadiseasemayleadtodevelopmentofdiagnosisandnoveltherapies.Webelievethatstudyingeachcasecarefullyisnecessaryforacliniciantounravelthecomplexityofthediseaseandtomoveintoanewparadigm.It’dbeathrillandexcitementforourteamthatyoujoinustofeelsuchdynamisminyourresearchandclinicalworkeveryday.in our team or through corporative studies with other medical institutionsclinical hematologyWeareengagedincancertreatment,educationandresearch.TheDepartmentofMedicalOncologyprovidesdrugtherapyforcancersthroughoutthebodyandalsodealswithmalignanttumorsthatareoftendifficulttodiagnoseandtreat,suchasrarecancersandcancersofunknownprimary.Weconductcancerresearchfromacross-organandbird's-eyeviewpoint.Wedesignandperformclinicalresearchesbasedonclinicalquestionsthatariseinthedailycancercare.?Research to explore predictive markers of efficacy and risk factors for side effects of immune checkpoint inhibitors and molecular targeted therapies.?Clinical research utilizing data from the Cancer Genome Collaboration Hospitals in Nagano Prefecture and cancer gene panel tests nationwide.TrainingatahospitaloncologydepartmentinNaganoPrefectureStudyabroadinJapan(NationalCancerCenteretc.)2024-2025医学科188bet体育_188bet备用网址紹介
元のページ ../index.html#39